Besides the reduction in total megalin levels, explained by increased receptor degradation, a possible mechanism involved in the decrease of megalin in the urine of LS patients is related to alterations in the proteolysis of the receptor ectodomain. The gene discussed is LRP2; the disease is Leigh syndrome.